SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/19/22 Ani Pharmaceuticals Inc. 424B3 1:203K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 424B3 Prospectus - New Facts or Events HTML 116K
tm2135647-4_424b3 - none - 3.6562653s |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 16 | | | |
| | | | 16 | | | |
| | | | 16 | | | |
| | | | 17 | | |
Names of Selling Stockholders
|
| |
Number of
Shares of Common Stock Owned Prior to Offering |
| |
Maximum
Number of Shares of Common Stock that may be Sold Pursuant to this Prospectus |
| |
Number of
Shares of Common Stock Owned After Offering |
| |
Percentage of
Class Following the Offering(1) |
| ||||||||||||
Esjay, LLC(2)
|
| | | | 1,332,620 | | | | | | 1,332,620 | | | | | | 0 | | | | | | 0% | | |
Ampersand 2020 Limited Partnership(3)
|
| | | | 602,901 | | | | | | 602,901 | | | | | | 0 | | | | | | 0% | | |
Chali Properties, LLC(4)
|
| | | | 383,226 | | | | | | 383,226 | | | | | | 0 | | | | | | 0% | | |
Thorappadi Vijayaraj
|
| | | | 191,613 | | | | | | 191,613 | | | | | | 0 | | | | | | 0% | | |
Kelsauryn Pharma Ventures, LLC(5)
|
| | | | 143,523 | | | | | | 143,523 | | | | | | 0 | | | | | | 0% | | |
Circle Pond Partners, LLC(6)
|
| | | | 127,742 | | | | | | 127,742 | | | | | | 0 | | | | | | 0% | | |
Bharath L. Surapanaene
|
| | | | 31,935 | | | | | | 31,935 | | | | | | 0 | | | | | | 0% | | |
The Jaikumar Family Trust(7)
|
| | | | 31,935 | | | | | | 31,935 | | | | | | 0 | | | | | | 0% | | |
Jeenarine Narine & Yearani Narine
|
| | | | 28,003 | | | | | | 28,003 | | | | | | 0 | | | | | | 0% | | |
Vani Kumar
|
| | | | 27,169 | | | | | | 27,169 | | | | | | 0 | | | | | | 0% | | |
BCI XII, LLC(8)
|
| | | | 25,763 | | | | | | 25,763 | | | | | | 0 | | | | | | 0% | | |
Chenguttai J. Manohar & Nirmala Manohar
|
| | | | 15,967 | | | | | | 15,967 | | | | | | 0 | | | | | | 0% | | |
Vijayakumar Karayi
|
| | | | 15,967 | | | | | | 15,967 | | | | | | 0 | | | | | | 0% | | |
Sathishkumar Palaniappan & Kavitha A. Sathishkumar
|
| | | | 15,967 | | | | | | 15,967 | | | | | | 0 | | | | | | 0% | | |
Muthusamy Shanmugam(9)
|
| | | | 13,460 | | | | | | 13,460 | | | | | | 0 | | | | | | 0% | | |
Other selling stockholders as a group(10)
|
| | | | 81,764 | | | | | | 81,764 | | | | | | 0 | | | | | | 0% | | |
This ‘424B3’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 1/19/22 | EFFECT | ||
1/18/22 | EFFECT | |||
12/17/21 | S-3 | |||
12/1/21 | ||||
11/19/21 | 3, 4, 8-K | |||
10/29/21 | ||||
9/30/21 | 10-Q | |||
6/30/21 | 10-Q | |||
3/31/21 | 10-Q, 4 | |||
3/9/21 | 8-K, DEFA14A | |||
3/8/21 | 8-K | |||
12/31/20 | 10-K | |||
12/31/19 | 10-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/26/21 Ani Pharmaceuticals Inc. 8-K:1,2,3,511/19/21 17:2.9M Toppan Merrill/FA 11/04/21 Ani Pharmaceuticals Inc. 8-K:1,9 11/03/21 12:521K Toppan Merrill/FA 11/03/21 Ani Pharmaceuticals Inc. 8-K:7,9 11/03/21 12:202K Toppan Merrill/FA 11/01/21 Ani Pharmaceuticals Inc. 10-Q 9/30/21 75:8.7M 8/06/21 Ani Pharmaceuticals Inc. 10-Q 6/30/21 76:8.7M 6/04/21 Ani Pharmaceuticals Inc. 8-K:5,7,9 6/02/21 11:5.6M Toppan Merrill/FA 5/07/21 Ani Pharmaceuticals Inc. 10-Q 3/31/21 76:7.3M 4/29/21 Ani Pharmaceuticals Inc. DEF 14A 6/02/21 1:5.8M Toppan Merrill/FA 3/11/21 Ani Pharmaceuticals Inc. 10-K 12/31/20 96:12M 3/09/21 Ani Pharmaceuticals Inc. 8-K:1,3,7,9 3/08/21 14:2.1M Toppan Merrill/FA 3/09/21 Ani Pharmaceuticals Inc. 8-K:2,9 3/09/21 11:486K Toppan Merrill/FA 2/17/21 Ani Pharmaceuticals Inc. 8-K:5,7,9 2/11/21 12:314K Toppan Merrill/FA 9/25/03 Ani Pharmaceuticals Inc. 8-A12B 2:21K Toppan Merrill-FA |